US COPD Coalition

Year: 2018

Dec
27

CDC Reports that Flu Season Has Arrived

According to the Centers for Disease Control & Prevention’s Weekly U.S. Influenza Surveillance Report, influenza activity in the United States has risen significantly, signaling the official start of the 2018-2019 flu season. The CDC monitors flu activity on a weekly basis, and when an analysis of that activity demonstrates a sustained increase across several key indicators, … Read more

Dec
17

CDC Urges You to Keep Active This Holiday Season

The U.S. Centers for Disease Control & Prevention (CDC) has issued some practical advice for staying active during the holiday season. “Not only does this festive season bring egg nog, cookies, candy canes and stuffing with extra gravy, in many areas it also means cooler temperatures”, notes the CDC. “Although being physically active can help you … Read more

Nov
20

NIH Statement on World COPD Day 2018

Wednesday, November 21, 2018 is World COPD Day, and the National Institues of Health (NIH) has published a statement on its committment to fight the burden of COPD. The following is the opening paragraph of the statement: On November 21, World COPD Day 2018, the National Institutes of Health unites with millions of people to … Read more

Nov
20

Webinar to Focus on the Impact of Commercial Tobacco on Tribal Communities

The FDA’s Office of Minority Health (OMH) invites you to join them as they host a webinar titled “The Impact of Commercial Tobacco on Tribal Communities: A Report Card”. The webinar is part of OMH’s Health Equity Lecture Series, and is being hosted in celebration of American Indian/Alaska Native Heritage Month. The webinar, which will be … Read more

Nov
19

Learn About the Symptoms, Diagnosis and Treatment of COPD

According to the Centers for Disease Control & Prevention (CDC), “chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, makes breathing difficult for the 16 million Americans who have been diagnosed with COPD. Millions more suffer from COPD, but have not been diagnosed and are not being treated.” November is National COPD Awareness … Read more

Nov
19

Protection Against Wildfire Smoke Requires Special Type of Face Mask

In addition to the unimaginable loss of life and property that the historic California wildfires are causing to the people in their path, a new health threat has emerged. The smoke from the wildfires that is enveloping much of California is very dangerous, particular for the very young, the elderly, and those with chronic heart … Read more

Nov
19

Learn About the Symptoms, Diagnosis and Treatment of COPD

According to the Centers for Disease Control & Prevention (CDC), “chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, makes breathing difficult for the 16 million Americans who have been diagnosed with COPD. Millions more suffer from COPD, but have not been diagnosed and are not being treated.” November is National COPD Awareness … Read more

Nov
18

Take the Kids4COPD Challenge

The U.S. COPD Coalition is helping to spread the word about the Kids4COPD Challenge, which is dedicated to raising awareness of COPD and focuses on getting the nation’s youth involved in raising that awareness. The Challenge has three steps: Step 1: Learn about COPD. The more you know, the better for you and your loved ones. People … Read more

Nov
16

FDA to Ban Most Flavored E-Cigarettes In Effort To Reduce Youth Nicotine Addiction

U. S. Food & Drug Administration (FDA) Commissioner Scott Gottlieb, MD, has announced that the FDA will immediately ban the sale of most flavors of electronic nicotine delivery systems (ENDS), commonly referred to as e-cigarettes, with the exception of tobacco and mint and menthol flavors. Menthol and mint flavored are not included in the ban … Read more

Nov
12

FDA Approves New COPD Maintenance Drug

The following news bulletin has been released by the U.S. Food & Drug Administration regarding a new tool in the management of COPD: Today, the U.S. Food and Drug Administration (FDA) approved Yupelri (revefenacin) Inhalation Solution for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Revefenacin is a long-acting muscarinic antagonist (LAMA), … Read more